United States · FDA National Drug Code directory
Hydralazine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-342_617acbb5-012a-416f-bf6c-fd766a25711c
- Product NDC
- 68462-342
- Form
- TABLET
- Composition / generic term
- Hydralazine Hydrochloride
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090529
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDRALAZINE HYDROCHLORIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68462-342-01) · 68462-342-01
- 500 TABLET in 1 BOTTLE (68462-342-05) · 68462-342-05
- 1000 TABLET in 1 BOTTLE (68462-342-10) · 68462-342-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →